北大医药实控人徐晰人被检方批捕

Group 1 - The actual controller and chairman of Beijing University Pharmaceutical, Xu Xiren, has been arrested for criminal charges as confirmed by the Chongqing Jiangbei District People's Procuratorate [1] - Xu Xiren's arrest follows a rapid sequence of events, starting from his temporary inability to perform duties on October 24, followed by his criminal detention on October 30, and culminating in his formal arrest on November 12, all within approximately 19 days [1] - Xu Xiren, aged 46, acquired control of Beijing University Pharmaceutical at a symbolic price of 1 yuan in December 2024, raising market interest [1] Group 2 - Following the change in control, significant personnel changes occurred within Beijing University Pharmaceutical, including the election of Xu Xiren as chairman and the appointment of other board members [2] - Internal conflicts surfaced when a board member, Mao Run, opposed his removal from the board, highlighting tensions within the company's leadership [2] - Reports suggest that Xu Xiren's acquisition was financed through short-term loans from Zhejiang Zhongbei Jiuzhou Group, indicating potential financial irregularities in the acquisition process [2] Group 3 - Just one day before Xu Xiren's arrest, Jiu Zhou Pharmaceutical announced that its 82-year-old founder, Hua Xuande, transferred his stakes in Zhongbei Group and Taizhou Gede to his daughters, effectively removing his indirect ownership in the company [3]